Close Menu

EMBL

Called Intervene, the project will use genomic and health data from biorepositories along with machine learning methods to develop new clinical predictive tools.

The European project will use single-cell profiling technologies to build well-characterized in vitro models of human organs and contribute to the Human Cell Atlas.

In Nature this week: new Sperm-seq method enables crossover analysis, tumor-informed detection approach for minimal residual disease, and more.

Launched last month as part of the EU's coronavirus action plan, the portal will collect and distribute SARS-CoV-2 sequencing and patient phenotype data.

The researchers identified rare germline loss-of-function variants across the ELP1 gene in 14 percent of pediatric patients in a medulloblastoma subgroup.

In Nature this week:  three-dimensional assay to visualize transposase-accessible chromatin, computational tool that uses variant information to map cells to clone of origin, and more.

In Nature this week: residual protein expression uncovered for a third of CRISPR targets, and more.

Researchers measured proteins produced by 193 deletions in 136 CRISPR-deleted genes and found residual protein expression in roughly one-third of these cases.

A pair of new fecal metagenomics studies pointed to gut microbial community shifts, related functional changes, and specific signatures for colorectal cancer.

The institute — part of the European Molecular Biology Laboratory — said it will use the new funding to increase its computing, storage, and building capacity.

Pages

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.